These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 19791824

  • 1. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR.
    Drugs; 2009 Oct 22; 69(15):2025-33. PubMed ID: 19791824
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Singh S, Loke YK, Furberg CD.
    JAMA; 2008 Sep 24; 300(12):1439-50. PubMed ID: 18812535
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S, Loke YK, Enright P, Furberg CD.
    Postgrad Med J; 2014 Apr 24; 90(1062):205-7. PubMed ID: 24643260
    [Abstract] [Full Text] [Related]

  • 9. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
    Nagy LB.
    Orv Hetil; 2015 Aug 02; 156(31):1246-52. PubMed ID: 26211748
    [Abstract] [Full Text] [Related]

  • 10. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S, Loke YK, Enright P, Furberg CD.
    Thorax; 2013 Jan 02; 68(1):114-6. PubMed ID: 22764216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
    Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA, Korducki L, Cassino C, Kesten S.
    Ann Intern Med; 2005 Sep 06; 143(5):317-26. PubMed ID: 16144890
    [Abstract] [Full Text] [Related]

  • 15. How safe are anticholinergics in patients with COPD?
    Hew MJ, Sestini P, Irving LB.
    Med J Aust; 2009 May 04; 190(9):468-9. PubMed ID: 19413514
    [Abstract] [Full Text] [Related]

  • 16. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR, ZuWallack RL.
    Expert Opin Pharmacother; 2004 Aug 04; 5(8):1827-35. PubMed ID: 15264997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
    Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.
    Ann Intern Med; 2007 Apr 17; 146(8):545-55. PubMed ID: 17310045
    [Abstract] [Full Text] [Related]

  • 20. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease.
    Yuan W, Nie S, Wang H, Xu Q, Jia N.
    BMC Pulm Med; 2019 May 09; 19(1):88. PubMed ID: 31072407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.